PAI‐1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

This publication has 43 references indexed in Scilit:

• Additional genetic risk factors for venous thromboembolismin carriers of the factor V Leiden mutation
  British Journal of Haematology, 1998
• Metabolic Determinants Are Much More Important Than Genetic Polymorphisms in Determining the PAI-1 Activity and Antigen Plasma Concentrations
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Five Frequent Polymorphisms of the PAI-1 Gene
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Gene Polymorphisms Predicting High Plasma Levels of Coagulation and Fibrinolysis Proteins
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US Men
  Circulation, 1997
• A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS
  Thrombosis Research, 1996
• The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
  American Journal of Obstetrics and Gynecology, 1995
• A rapid screening method for the factor V Arg506???Gln mutation
  Blood Coagulation & Fibrinolysis, 1995
• Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene
  Diabetes, 1995